Company / Current Liabilities
Lexaria Bioscience Corp. Current Liabilities History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$1.5M
FY2025
5-year range
$153.3K / $1.5M
FY2021-FY2025
Trend
+35.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has increased for 4 consecutive years, from $153,276 in FY2021 to $1M in FY2025.
Based on SEC 10-K filings.
$1M in FY2025 with a 10-year CAGR of +39.1%.
Increased from $267,735 to $1M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +97.4%
- 5-Year CAGR
- +45.9%
- 10-Year CAGR
- +39.1%
Key checks
Key Insights
- Lexaria Bioscience Corp.'s current liabilities has grown for 4 consecutive years.
- 5-year CAGR of +45.9%, indicating consistent growth.
- In FY2025, current liabilities increased 35.8% year-over-year.
- Lowest current liabilities in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.5M | +35.8% |
| FY2024 | $1.1M | +310.6% |
| FY2023 | $267.7K | +38.0% |
| FY2022 | $194.0K | +26.6% |
| FY2021 | $153.3K | -32.2% |
| FY2020 | $225.9K | +22.4% |
| FY2019 | $184.5K | +99.8% |
| FY2017 | $92.3K | -78.7% |
| FY2016 | $433.9K | +687.1% |
| FY2015 | $55.1K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026